Amazentis
PrivateLast Round
Grant
May 19, 2025
Total Funding Raised
$87.36M
Company Overview
Amazentis is a biotechnology company that develops nutritional and skincare products to combat aging and improve quality of life.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Fashion & Beauty
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amazentis Comparables
Compare Amazentis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MitoQ | 88% | |
| Elysium Health | 83% | |
| NOVOS | 80% | |
Amazentis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 19, 2025 | ||||
| Series D | Jan 17, 2024 | ||||
| Series B | Sep 25, 2023 | ||||
| Corporate Funding | Apr 2, 2019 | ||||
| Series C | Mar 21, 2018 |
Amazentis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BlackFin Capital Partners | Series B |
| Climb Ventures | Series D |
| ND Capital | Series C |
| BOLD (Business Opportunities for L'Oréal Development) | Series D |
| MTech Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2025
Secured $250K in grant funding.
- May 12, 2025
Recognized as a Top 40 global team for innovative approaches.
Amazentis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amazentis's valuation, stock price, and market status.